THERAPEUTIC APHERESIS AND DIALYSIS

Scope & Guideline

Exploring cutting-edge methodologies in apheresis and dialysis.

Introduction

Immerse yourself in the scholarly insights of THERAPEUTIC APHERESIS AND DIALYSIS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1744-9979
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTHER APHER DIAL / Ther. Apher. Dial.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "Therapeutic Apheresis and Dialysis" focuses on advancing the knowledge and practice of therapeutic apheresis and dialysis, encompassing a wide range of conditions and treatment modalities. Its scope includes clinical applications, innovative therapies, and research findings that contribute to the understanding of renal replacement therapies and their impact on patient outcomes.
  1. Therapeutic Apheresis:
    The journal emphasizes the role of therapeutic apheresis in treating various medical conditions, including autoimmune disorders, hematological diseases, and complications arising from chronic kidney disease. It includes studies on the efficacy and safety of procedures such as plasma exchange and leukapheresis.
  2. Dialysis Modalities:
    Research on different dialysis modalities, including hemodialysis and peritoneal dialysis, is a core focus. The journal covers topics related to the optimization of dialysis techniques, patient management, and long-term outcomes of dialysis therapies.
  3. Innovative Treatment Approaches:
    The journal highlights innovative treatment approaches, such as the use of machine learning in predicting patient outcomes, novel dialysis membranes, and blood purification technologies. This includes advancements in therapeutic devices and their clinical applications.
  4. Patient-Centered Care:
    Studies focusing on patient-centered care, quality of life, and psychosocial aspects of treatment in patients undergoing dialysis and apheresis are integral. This includes research on patient education, adherence to treatment, and shared decision-making.
  5. Epidemiology and Outcomes:
    The journal publishes epidemiological studies that assess patient populations undergoing dialysis and apheresis, detailing outcomes related to mortality, morbidity, and complications associated with these therapies.
The journal has shown a dynamic evolution in its research focus, with certain themes emerging as significant areas of interest. These trends reflect current healthcare challenges, technological advancements, and the increasing importance of personalized medicine.
  1. Machine Learning and Predictive Analytics:
    There is a growing trend towards utilizing machine learning and predictive analytics in the management of dialysis and apheresis patients. This includes developing models to predict outcomes such as mortality and treatment response, indicating a shift towards data-driven decision-making.
  2. Patient Quality of Life and Psychosocial Factors:
    Recent publications have increasingly focused on the quality of life, mental health, and psychosocial factors affecting patients undergoing dialysis and apheresis. This trend highlights the importance of holistic care in managing chronic kidney disease.
  3. Advanced Dialysis Technologies:
    Emerging technologies, such as medium-cut-off dialyzers and innovative blood purification methods, are gaining traction in the literature. Research into these advanced modalities aims to improve patient outcomes and reduce complications.
  4. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on patients undergoing dialysis and apheresis has led to a surge in related research. Studies addressing infection rates, vaccine responses, and management strategies during the pandemic have become increasingly relevant.
  5. Nutritional Interventions:
    An increasing number of studies are focusing on nutritional interventions and their effects on patients undergoing dialysis. This emerging theme explores the links between nutrition, inflammation, and overall health outcomes in this population.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have seen a decline in focus over recent years. These waning scopes may reflect shifting priorities in research or advancements that have reduced the need for investigation in those areas.
  1. Basic Science Research:
    There has been a noticeable decline in basic science research related to the mechanisms of apheresis and dialysis. As clinical applications and outcomes take precedence, foundational studies seem to be less frequently published.
  2. Traditional Dialysis Techniques:
    Research focusing solely on traditional dialysis techniques without innovation or comparative analysis appears to be waning. As newer technologies and methodologies are developed, studies on conventional approaches are becoming less prominent.
  3. Apheresis in Non-Renal Diseases:
    The exploration of apheresis applications in non-renal diseases has decreased. While apheresis remains relevant for renal conditions, its use in broader medical contexts appears less frequently discussed in recent publications.
  4. Longitudinal Studies:
    Longitudinal studies that track outcomes over extended periods have become less common. This may reflect a shift towards more immediate, short-term studies that provide quicker results and insights.
  5. Economic Evaluations:
    Research focusing on the economic aspects of apheresis and dialysis, including cost-effectiveness analyses, seems to be less represented. As funding and resources shift, this area may be receiving less attention.

Similar Journals

International Journal of Nephrology

Championing open access to vital kidney research.
Publisher: HINDAWI LTDISSN: 2090-214XFrequency: 1 issue/year

The International Journal of Nephrology is a premier peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of nephrology through the dissemination of high-quality research. With an ISSN of 2090-214X and an E-ISSN of 2090-2158, this open-access journal has been providing a platform for scholarly articles since 2010, ensuring that both researchers and practitioners have immediate access to the latest findings in kidney health and disease. As of 2023, it holds a reputable Q2 rating in the nephrology category, ranking 36th out of 81 journals in Scopus, placing it in the 56th percentile. The journal aims to foster innovation and collaboration within the nephrology community by covering a broad scope of topics, including clinical and experimental research, innovative treatments, and public health initiatives related to kidney disorders. Situated in the United States, the International Journal of Nephrology is committed to enhancing understanding and improving outcomes in nephrology by bridging academia with clinical practice, making it an essential resource for academics, clinicians, and students alike.

TRANSFUSION MEDICINE AND HEMOTHERAPY

Elevating the standards of hemotherapy and transfusion practices.
Publisher: KARGERISSN: 1660-3796Frequency: 6 issues/year

TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.

Kidney Diseases

Connecting researchers and clinicians for kidney health breakthroughs.
Publisher: KARGERISSN: 2296-9381Frequency: 6 issues/year

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.

Clinical and Experimental Nephrology

Empowering professionals with high-quality nephrology research.
Publisher: SPRINGERISSN: 1342-1751Frequency: 6 issues/year

Clinical and Experimental Nephrology, published by SPRINGER, serves as a crucial platform for researchers and practitioners in the field of nephrology. With its roots dating back to 1999, the journal has made significant strides in exploring various dimensions of kidney health, thereby enriching our understanding of nephrological diseases. Aimed at fostering interdisciplinary dialogue, it covers a broad spectrum of topics from clinical practices to experimental research, evidenced by its ranked quartiles of Q2 in Nephrology and Q3 in both Physiology and Medical Physiology within its latest evaluation. Although not open access, the journal's rigorous peer-review process ensures the publication of high-quality research, making it a valuable resource for professionals, academic institutions, and students. The journal is located in Japan, with its editorial office situated at One New York Plaza, Suite 4600, New York, NY 10004, United States, reflecting its global influence and intent to disseminate critical findings in nephrology and beyond.

SEMINARS IN DIALYSIS

Exploring the forefront of kidney health and dialysis advancements.
Publisher: WILEYISSN: 0894-0959Frequency: 6 issues/year

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

Kidney Medicine

Bridging research and practice in nephrology.
Publisher: ELSEVIERISSN: 2590-0595Frequency: 6 issues/year

Kidney Medicine is a pioneering Open Access journal dedicated to advancing the field of nephrology and internal medicine, published by Elsevier. Since its inception in 2019, it has rapidly established itself as a vital resource, currently ranked in the Q2 category for Internal Medicine and Q1 for Nephrology by 2023, reflecting its influence and critical contributions to both disciplines. With an impressive Scopus ranking, positioning it at #24 out of 81 in Nephrology, the journal serves as an essential platform for researchers, clinicians, and students eager to disseminate and access high-quality research. By providing open access to a diverse array of articles, Kidney Medicine ensures that vital research reaches a wide audience, thereby facilitating knowledge exchange and innovation within the community. Its ongoing commitment to excellence and relevance makes it a key player in shaping the future of kidney health worldwide.

Case Reports in Nephrology and Dialysis

Uncovering the complexities of nephrology, one case at a time.
Publisher: KARGERISSN: 2296-9705Frequency: 3 issues/year

Case Reports in Nephrology and Dialysis, published by KARGER, is a vital peer-reviewed journal dedicated to the dissemination of case reports and innovative findings in the fields of nephrology and dialysis. Since its inception in 2015, this Open Access journal has aimed to foster knowledge exchange and improve patient outcomes through comprehensive case studies, clinical insights, and recent advancements in renal healthcare. Based in Switzerland, the journal is poised to serve a global audience, accommodating research that spans diverse geographical and clinical contexts. Currently ranked in the Q3 category for nephrology in 2023, it underscores its burgeoning influence in the medical literature, despite its relatively nascent presence. As a valuable resource for researchers, healthcare professionals, and students, it provides a platform for sharing unique cases that enrich the understanding of complex renal issues and challenges faced in dialysis. With an emphasis on high-quality, accessible research, Case Reports in Nephrology and Dialysis is committed to advancing nephrology and dialysis practices through collaboration and knowledge sharing.

Nephrologie & Therapeutique

Uniting research and practice in kidney disease management.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1769-7255Frequency: 7 issues/year

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

Kidney360

Empowering nephrology with cutting-edge insights.
Publisher: AMER SOC NEPHROLOGYISSN: 2641-7650Frequency: 12 issues/year

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

NEFROLOGIA

Transforming nephrology through scholarly collaboration.
Publisher: SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZISSN: 0211-6995Frequency: 6 issues/year

NEFROLOGIA is a preeminent scientific journal published by the SOCIEDAD ESPAÑOLA DE NEFROLOGÍA DR. RAFAEL MATESANZ, specializing in cutting-edge research and clinical advancements in the field of nephrology. Established in 1981 and continuing through 2024, this journal serves as a crucial platform for nephrologists, researchers, and healthcare professionals to disseminate knowledge and foster dialogue on critical issues affecting kidney health. With its ISSN 0211-6995 and E-ISSN 1989-2284, NEFROLOGIA is indexed in prestigious databases, ranking #35 out of 81 in the Scopus Medicine Nephrology category, reflecting its significance within the medical community. Although it does not currently offer open access, the journal ensures wide accessibility and readership through institutional subscriptions. Researchers and clinicians are invited to contribute their findings and reviews, advancing our understanding and treatment of renal diseases. Through its commitment to high scholarly standards and impactful research, NEFROLOGIA remains a vital resource for those dedicated to improving kidney care and advancing nephrology sciences.